Medicenna Therapeutics
Why Robinhood?
You can watch MDNAF and buy or sell other stocks, ETFs, and their options commission-free!About MDNAF
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers.
MDNAF Key Statistics
Stock Snapshot
Medicenna Therapeutics(MDNAF) stock is priced at $0.25, giving the company a market capitalization of 19.02M. It carries a P/E multiple of -1.53.
On 2026-07-28, Medicenna Therapeutics(MDNAF) stock moved within a range of $0.25 to $0.25. With shares now at $0.25, the stock is trading 0.0% above its intraday low and -2.4% below the session's peak.
Trading volume for Medicenna Therapeutics(MDNAF) stock has reached 2.5K, versus its average volume of 44.34K.
The stock's 52-week range extends from a low of $0.23 to a high of $1.43.
The stock's 52-week range extends from a low of $0.23 to a high of $1.43.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.